Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Target-specific catecholamine elevation induced by anticonvulsant thalamic deep brain stimulation.

Wendy C Ziai1, David L Sherman, Anish Bhardwaj

  • 1Division of Neurosciences Critical Care, the John's Hopkins University School of Medicine, Baltimore, Maryland 21287, USA. weziai@jhmi.edu

Epilepsia
|June 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurocritical Care Fellowship Training in the USA: Challenges and Potential Solutions.

Neurocritical care·2026
Same author

Trends in Industry-sponsored Research Payments to Anesthesiologist Principal Investigators.

Anesthesiology·2026
Same author

Evolution of the Departmental Chair in US Academic Medical Institutions: A Descriptive Appraisal.

Journal of healthcare leadership·2025
Same author

Rapid sepsis diagnosis with protease activity measurement.

medRxiv : the preprint server for health sciences·2025
Same author

Challenges in effective communication for end-of-life decision making in clinical practice.

Hospital practice (1995)·2025
Same author

Anonymous versus Open Evaluative Feedback in US Academic Medical Institutions: Pros and Cons.

Advances in medical education and practice·2025

Anterior thalamic nucleus deep brain stimulation (DBS) enhances seizure threshold by modulating specific brain chemistry. This study shows DBS specifically increases serotonin activity in the anterior thalamic nucleus, suggesting a key role in its anticonvulsant effects.

Area of Science:

  • Neuroscience
  • Neurochemistry
  • Epilepsy Research

Background:

  • Anterior thalamic nucleus (AN) deep brain stimulation (DBS) is a known effective method for increasing seizure thresholds in experimental models.
  • The precise mechanisms by which DBS exerts its anticonvulsant effects remain incompletely understood.
  • Investigating the neurochemical alterations within the AN during DBS is crucial for understanding its therapeutic potential.

Purpose of the Study:

  • To test the hypothesis that experimental seizures and AN DBS modify the regional neurochemistry of the AN.
  • To investigate the specific role of the serotonergic system in the anticonvulsant action of AN DBS.
  • To determine if local electrical stimulation facilitates serotonergic activity in the AN.

Main Methods:

Related Experiment Videos

  • Stereotactically guided bilateral implantation of electrodes and microdialysis probes in the AN and posterior thalamus (PT) of rats.
  • Administration of intravenous pentylenetetrazol (PTZ) to induce seizures in both stimulated (AN DBS) and non-stimulated control groups.
  • Simultaneous recording of thalamic and cortical EEG and collection of microdialysis samples to measure neurochemical changes.

    • Main Results:

    • Bilateral AN DBS significantly delayed the onset of EEG seizures induced by PTZ compared to controls (82±8 vs. 58±5 min, p=0.02).
    • PTZ infusion, with or without AN DBS, increased norepinephrine (NE) levels in both AN and PT, but not dopamine.
    • A selective increase in 5-hydroxyindoleacetic acid (5-HIAA), a serotonin metabolite, was observed in the AN during AN DBS and PTZ infusion, indicating enhanced serotonergic activity.

    Conclusions:

    • AN DBS and PTZ administration together promote non-specific norepinephrine release in thalamic nuclei.
    • AN DBS specifically enhances localized serotonergic activity within the AN, as evidenced by increased 5-HIAA levels.
    • Modulation of AN-specific serotonergic neurotransmission is a critical factor underlying the anticonvulsant efficacy of AN DBS.